RecruitingNot ApplicableNCT06563531

Are Elastic Restraints Still Necessary in Improved Rehabilitation Programs After Hip and Knee Prosthetic Surgery?


Sponsor

Clinique Pasteur Lanroze

Enrollment

1,274 participants

Start Date

Nov 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Venous thrombosis and pulmonary embolism are considered serious and potentially preventable complications of hip and knee replacement surgery. The risks of thrombosis must be weighed against the risks associated with preventive measures, both mechanical and pharmacological. Modern medicine is now questioning the use of elastic restraints in surgery. Several studies have investigated the benefits of using restraints to prevent thromboembolic events. These studies have shown no additional benefit from the use of compression stockings in thromboembolism prevention. To the best of our knowledge, no orthopedic study has investigated the non-inferiority of pharmacological treatment compared with elastic compression devices, specifically in knee and hip surgery. The aim of this multicenter, prospective, randomized study is to investigate whether pharmacological prophylaxis alone is non-inferior to pharmacological and mechanical prophylaxis (using restraints) of peripheral venous thrombosis or pulmonary embolism up to 90 days after prosthetic surgery.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • first line and non-traumatic total hip or knee arthroplasty
  • Patient included in an Enhanced Rehabilitation after Surgery (ERS) or "fast-track" protocol, or scheduled as an outpatient.

Exclusion Criteria20

  • Patient requiring long-term anticoagulation for pre-existing co-morbidity
  • Patients with coagulation disorders (hypercoagulability)
  • Patient undergoing thrombogenic pharmacological treatment
  • History of obliterative arteriopathy of the lower limbs
  • Arterial disease
  • Obesity
  • Heart failure
  • Chronic bronchopneumopathy
  • Lymphedema
  • Chronic inflammatory disease
  • Permanent wearing of elastic restraints
  • Proximal or distal arterial bypass surgery
  • Creatinine clearance < 15 ml/min
  • Inability to give consent
  • Revision surgery for hip or knee prosthesis
  • Metastatic cancer
  • Life expectancy less than 3 months
  • Allergy to socks or compression stockings
  • Adults under guardianship or curatorship
  • Vulnerable persons in accordance with article L1121-6 of the CSP (French Public Health Code)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPharmacological thromboprophylaxis and elastic compression

Patients benefit from thromboembolism prevention through pharmacological thromboprophylaxis and elastic restraint after total hip or knee arthroplasty.

PROCEDUREPharmacological thromboprophylaxis without elastic compression

Patients benefit from thromboembolism prevention through pharmacological thromboprophylaxis only after total hip or knee arthroplasty.


Locations(1)

Clinique Pasteur Lanroze

Brest, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06563531


Related Trials